PROCEPT BioRobotics Faces Securities Fraud Lawsuit Over Inventory Issues

PROCEPT BioRobotics Corporation is the subject of a securities fraud class action lawsuit concerning alleged undisclosed inventory issues. The lawsuit claims the company failed to inform investors about material problems with its inventory, which subsequently impacted its financial standing.

The legal action follows a notable decline of approximately 18% in PROCEPT BioRobotics' stock price. The law firm Kahn Swick & Foti, LLC (KSF), representing investors, links this stock drop to the company's reported inventory challenges. The suit alleges that the company neglected its duty to disclose these significant risks to investors before they materially affected the stock's value.

KSF has issued a reminder to investors who have experienced substantial losses, stating they have until September 22, 2026, to file applications to be lead plaintiff in the litigation. KSF and its partner, former Louisiana Attorney General Charles C. Foti, Jr., are known for their work in securities litigation and aim to represent shareholders adversely affected by the company's alleged misconduct.

The lawsuit seeks to recover damages for investors who have suffered losses due to the company's purported failure to comply with disclosure requirements. PROCEPT BioRobotics has not yet publicly commented on the lawsuit or the specific allegations detailed within it.